In some embodiments, the lipid-based drug delivery formulation or composition comprises a penetration enhancer wherein the penetration enhancer is gluconolactone (e.g., glucono-D-lactone), either alone or in up to a 1:1 ratio with another enhancer, such as propylene glycol
pmid:24587240
The reduction of IIS in Laron subjects unmasks the potential role of persistent hyperactive IIS mediated by Western diet in the development of diseases of civilization and offers a rational perspective for dietary adjustments with less insulinotropic diets like the Paleolithic diet
Rotate sites systematically (abdomen avoiding 2inch radius around navel, outer thighs, upper arms) to avoid lipohypertrophy [8]
GHK-Cu is not a drug, supplement, or food product, and is not for human consumption, veterinary use, or medical applications